Literature DB >> 10382097

Simplified reference region model for the kinetic analysis of [99mTc]TRODAT-1 binding to dopamine transporters in nonhuman primates using single-photon emission tomography.

P D Acton1, S A Kushner, M P Kung, P D Mozley, K Plössl, H F Kung.   

Abstract

Accurate quantification of neuroreceptors requires full kinetic modeling of the dynamic single-photon emission tomography (SPET) or positron emission tomography (PET) images, with highly invasive arterial blood sampling. This study investigated the application of a reference region kinetic model to the dynamics of [99mTc]TRODAT-1 in nonhuman primates, obviating the need for blood sampling. A series of dynamic SPET scans were performed on two baboons following the injection of approximately 700 MBq of [99mTc]TRODAT-1. Rapid arterial blood samples were taken automatically during scanning. Reconstructed SPET images were coregistered with magnetic resonance imaging (MRI) scans of the baboons, and regions of interest (ROIs) placed on the striatum, cerebellum and cerebral hemispheres. The ROI data were combined with metabolite-corrected blood data, and fitted to a three-compartment kinetic model using nonlinear least squares techniques. The same data were also used in a simplified reference region model, in which the input function was derived from the nondisplaceable tissue compartment. In addition, semiquantitative blinded analysis was performed by three raters to determine the point of transient equilibrium in the specific binding curves. All methods generated values for the ratio of the kinetic rate constants k3/k4, which gives an estimate of the binding potential, BP. These were compared with the full kinetic model. The mean values of k3/k4 for the three different analysis techniques for each baboon were: 1.17 +/- 0.21 and 1.12 +/- 0.13 (full kinetic model), 0.93 +/- 0.13 and 0.90 +/- 0.07 (reference region model), and 0.97 +/- 0.18 and 0.92 +/- 0.08 (equilibrium method). The reference region method gave significantly lower results than the full kinetic model (P = 0.01), but it also produced a much smaller spread and better quality fits to the kinetic data. The reference region model results for k3/k4 correlated very strongly with the full kinetic analysis (r2 = 0.992, P < 0.001), and with the equilibrium model (r2 = 0.88, P = 0.002). The subjectivity inherent in the equilibrium method produces inferior results compared with both kinetic analyses. It is suggested that the self-consistency of the reference region model, which requires no arterial blood sampling, provides a more precise and reliable estimate of the binding of [99mTc]TRODAT-1 to dopamine transporters than full kinetic modeling. The reference region method is also better suited to a routine clinical environment, and would be able to distinguish smaller differences in dopaminergic function between patient groups.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10382097     DOI: 10.1007/s002590050420

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  10 in total

Review 1.  A review of imaging agent development.

Authors:  Eric D Agdeppa; Mary E Spilker
Journal:  AAPS J       Date:  2009-05-05       Impact factor: 4.009

2.  Quantitative evaluation of simultaneous reconstruction with model-based crosstalk compensation for 99mTc/123I dual-isotope simultaneous acquisition brain SPECT.

Authors:  Yong Du; Eric C Frey
Journal:  Med Phys       Date:  2009-06       Impact factor: 4.071

3.  SPECT imaging of serotonin transporter binding in patients with generalized anxiety disorder.

Authors:  Eduard Maron; Jyrki T Kuikka; Kai Ulst; Jari Tiihonen; Veiko Vasar; Jakov Shlik
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2004-11-12       Impact factor: 5.270

4.  Greater striatal dopamine transporter density may be associated with major depressive episode.

Authors:  Jay D Amsterdam; Andrew B Newberg; Irene Soeller; Justine Shults
Journal:  J Affect Disord       Date:  2012-04-04       Impact factor: 4.839

5.  Age-related decline in motor behavior and striatal dopamine transporter in cynomolgus monkeys.

Authors:  Feng Yue; Sien Zeng; Di Wu; Deqiao Yi; Y Alex Zhang; Piu Chan
Journal:  J Neural Transm (Vienna)       Date:  2012-02-11       Impact factor: 3.575

6.  A linear algorithm of the reference region model for DCE-MRI is robust and relaxes requirements for temporal resolution.

Authors:  Julio Cárdenas-Rodríguez; Christine M Howison; Mark D Pagel
Journal:  Magn Reson Imaging       Date:  2012-12-08       Impact factor: 2.546

7.  Dopamine transporter levels in cocaine dependent subjects.

Authors:  Paul Crits-Christoph; Andrew Newberg; Nancy Wintering; Karl Ploessl; Mary Beth Connolly Gibbons; Sarah Ring-Kurtz; Robert Gallop; Julie Present
Journal:  Drug Alcohol Depend       Date:  2008-06-20       Impact factor: 4.492

Review 8.  PE2I: a radiopharmaceutical for in vivo exploration of the dopamine transporter.

Authors:  Patrick Emond; Denis Guilloteau; Sylvie Chalon
Journal:  CNS Neurosci Ther       Date:  2008       Impact factor: 5.243

9.  Influence of serotonin transporter gene polymorphism (5-HTTLPR polymorphism) on the relation between brain 5-HT transporter binding and heart rate corrected cardiac repolarization interval.

Authors:  Esa Kauppila; Esko Vanninen; Salla Kaurijoki; Leila Karhunen; Kirsi H Pietiläinen; Aila Rissanen; Jari Tiihonen; Ullamari Pesonen; Jaakko Kaprio
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240

10.  Elevated midbrain serotonin transporter availability in mixed mania: a case report.

Authors:  Tommi Tolmunen; Mikko Joensuu; Pirjo Irmeli Saarinen; Hanna Mussalo; Pasi Ahola; Ritva Vanninen; Jyrki Kuikka; Jari Tiihonen; Johannes Lehtonen
Journal:  BMC Psychiatry       Date:  2004-09-13       Impact factor: 3.630

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.